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Introduction
A Caucasian family with an affected mother and 2
affected daughters presented with early onset Behçet–
like disease, manifesting with arthralgia/arthritis, mouth
and genital ulcers, and uveitis. They are negative for
HLA*B51. Their symptoms are significantly ameliorated
with TNF-inhibitors.
Objectives
To identify the causative mutation(s) in this family we
sequenced the exomes of the 3 affected patients.
Methods
Exome data were filtered for novel variants not present
in dbSNP, the 1000 Genomes Pilot Project, NHLBI
Exome Sequencing Project (ESP5400), and 124 exomes
from in-house data.
Results
We identified 21 putative candidate variants that are
both novel and consistent with dominant inheritance.
Sanger sequencing validated all 21 variants. Three variants
identified in TNFRSF9, MGEA5, and TNFAIP3 genes were
confirmed to have arisen de novo in the affected mother
based on the genotyping of the healthy maternal grand-
mother, the maternal unaffected brother, and the unaf-
fected paternal aunt. The candidate variant in MGEA5 was
predicted as benign by PolyPhen-2. The 2 candidate var-
iants that remained for consideration are p.C78W
(TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP3;A20).
Haplotype analysis showed that p.C78W occurred de novo
on the haplotype inherited from the grandmother. The
p.L227X mutation-associated haplotype was found on the
grandfather’s haplotype; his sample is not available for
analysis. Because we reached the limit for further analysis
of candidate variants in the family, we studied 6 Turkish
familial Behçet cases and 56 sporadic Caucasian cases. All
of these individuals were negative for mutations in either
candidate gene. Both 4-1BB and A20 are strong candidates
and potentially in the same signaling pathway. 4-1BB is a
TNF-family receptor that costimulates T cell responses
and promotes survival of lymphocytes and dendritic cells;
A20 is a negative regulator of NF-kB activation by TNF
and TLR family receptors. Mutant 4-1BB expressed in
Jurkat cells was associated with reduced expression on the
plasma membrane, and activated T cells from all 3
patients had a marked decrease in surface expression,
especially in CD8+ T cells. Despite reduced surface expres-
sion, the C78W TNFRSF9 mutation could have a gain-of-
function phenotype like TNFR1 mutations in TRAPS,
leading to intracellular retention of mutant protein and
spontaneous signaling, which in this case could amplify
immune responses by T cells and other cell types expres-
sing 4-1BB. Patient peripheral blood cells also had lower
total A20 protein levels relative to controls and, consistent
with A20 lack of function, increased I-B degradation
after cellular activation.
Conclusion
Behçet-like disease in this family is associated with
mutations in 2 genes that affect immune cell survival
and production of inflammatory cytokines. Additional
functional studies will determine whether 1 or both
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